Background: The highest incidence and mortality rates of this cancer have been observed in Asia. In the current research, an estimate of localized renal cell carcinoma survival in Asia is presented. Methods: In the present meta-analysis study, 6 scientific databases of the world were used to search for related articles. Inclusion criteria included cross-sectional, cohort and case-control studies. Articles published until the middle of 2022 were reviewed. The risk of bias in the studies was reduced by using the random-effects model. Results: Overall, 41 papers had criteria for addition in the analysis. Survival in 5 years was at 68.60% (95% CI 65.80–71.30). The meta-regression results displayed an important association among publish year and survival rate. Also, human development index was a reason of variability in finding of survival rate. Conclusion: Compared to European countries and the United States, the survival rate for kidney cancer in Asia is lower.
Delam et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: